Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Hallie Graor"'
Autor:
Mei Zhang, Liane Chun, Victor Sandoval, Hallie Graor, Jay Myers, Joseph Nthale, Peter Rauhe, Zachary Senders, Kevin Choong, Alex Y. Huang, Julian Kim
Publikováno v:
OncoImmunology, Vol 7, Iss 2 (2018)
Converting an immunosuppressive melanoma microenvironment into one that favors the induction of antitumor immunity is indispensable for effective cancer immunotherapy. In the current study we demonstrate that oat-derived β-(1-3)-(1-4)-glucan of 200
Externí odkaz:
https://doaj.org/article/ee2cc95137d94b4dae17730f4b3f3103
Publikováno v:
Journal of Immunology Research, Vol 2015 (2015)
Background. The purpose of this study was to determine the cellular effectors of both the adoptively transferred cells and the tumor-bearing host that participate in the antitumor response to adoptive immunotherapy using culture-activated tumor-drain
Externí odkaz:
https://doaj.org/article/9a3de18fc0514aa995e14ab2543db779
Autor:
Omid Hajihassani, Ali Vaziri-Gohar, Mehrdad Zarei, Jonathan Hue, Helen Cheng, Anusha Mudigonda, Erryk Katayama, Hallie Graor, Jordan Winter
Publikováno v:
Cancer Research. 82:3021-3021
With an overall survival of less than 3%, pancreatic ductal adenocarcinoma (PDAC) is the 3rd leading cause of cancer-related death in the U.S. at its advanced stages. With the most promising therapeutics, the overall survival after a stage IV PDAC di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c35fd00fde2838d44523bd39935d413d
https://doi.org/10.1158/1538-7445.am2022-3021
https://doi.org/10.1158/1538-7445.am2022-3021
Autor:
Mehrdad Zarei, Ali Vaziri-Gohar, Jonathan Hue, Omid Hajihassani, Erryk Katayama, Hallie Graor, Jordan Winter, Luke Rothermel
Publikováno v:
Cancer Research. 82:3038-3038
Introduction: Novel immunotherapies and targeted therapies have generated remarkable responses for patients with melanoma relative to historic treatments, but these responses are only seen in about 50% of patients. This suggests that treatment resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cfb42f0cac18bf66439683ca3e910e9
https://doi.org/10.1158/1538-7445.am2022-3038
https://doi.org/10.1158/1538-7445.am2022-3038
Publikováno v:
Journal of Immunotherapy. 39:15-26
Our laboratory has previously demonstrated that melanoma draining lymph node (MDLN) samples from stage III patients contained both CD4 and CD8 T cells that can be readily expanded to mediate tumor cell apoptosis in vitro and improve survival in mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d40501a482b26b82eea3fce811a19b19
https://doi.org/10.1097/cji.0000000000000103
https://doi.org/10.1097/cji.0000000000000103
Autor:
Mei Zhang, Liane Chun, Jay Myers, Victor Sandoval, Zachary Senders, Peter Rauhe, Alex Yee-Chen Huang, Joseph Nthale, Julian A Kim, Hallie Graor, Kevin Choong
Publikováno v:
OncoImmunology, Vol 7, Iss 2 (2018)
Converting an immunosuppressive melanoma microenvironment into one that favors the induction of antitumor immunity is indispensable for effective cancer immunotherapy. In the current study we demonstrate that oat-derived β-(1-3)-(1-4)-glucan of 200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d0975406b07a3c7c9d81e2e10171706
https://europepmc.org/articles/PMC5749667/
https://europepmc.org/articles/PMC5749667/
Publikováno v:
Surgery. 152:557-566
Background Adoptive immunotherapy for patients with metastatic melanoma has yielded encouraging results. However, methods of expanding melanoma-specific T cells from stage III are limited. The objective of this study was to determine whether melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd24ff2378249ad67c33aabc563c497f
https://doi.org/10.1016/j.surg.2012.07.002
https://doi.org/10.1016/j.surg.2012.07.002
Autor:
Julian A Kim, Jaroslaw P. Maciejewski, Kevin Rothchild, Poornima B. Rao, Christine L. O'Keefe, Hallie Graor
Publikováno v:
Surgery. 136:295-302
Antigen-specific T cells undergoing clonal expansion share common rearrangements of the variable complementary determining region 3 (CDR3) of the T-cell receptor (TCR), which can be identified using polymerase chain reaction-based V beta (VB) spectra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61d94a33b216f218d250bb80445b611f
https://doi.org/10.1016/j.surg.2004.05.003
https://doi.org/10.1016/j.surg.2004.05.003
Autor:
Li-Xin, Wang, Wen-Xin, Huang, Hallie, Graor, Peter A, Cohen, Julian A, Kim, Suyu, Shu, Gregory E, Plautz
Publikováno v:
Journal of Translational Medicine, Vol 2, Iss 1, p 41 (2004)
Journal of Translational Medicine
Journal of Translational Medicine
T cell-mediated cancer immunotherapy is dose dependent and optimally requires participation of antigen-specific CD4+ and CD8+ T cells. Here, we isolated tumor-sensitized T cells and activated them in vitro using conditions that led to greater than 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::185cf863d088922801410bba179ec4d5
http://www.translational-medicine.com/content/2/1/41
http://www.translational-medicine.com/content/2/1/41
Autor:
Michael S Srodes, Richard Bergstrom, Damon A Silverman, Julian A Kim, Hallie Graor, Jorgen Kjaergaard
Publikováno v:
Otolaryngology–Head and Neck Surgery. 129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c16832fa93c3b867b6ee851651b939f8
https://doi.org/10.1016/s0194-59980301014-3
https://doi.org/10.1016/s0194-59980301014-3